Thermo Fisher Introduces Homologous Recombination Deficiency Score for Cancer Profiling Assay
360Dx,
NEW YORK – Thermo Fisher Scientific is throwing its hat into the ring of homologous recombination deficiency cancer testing…
NEW YORK – Thermo Fisher Scientific is throwing its hat into the ring of homologous recombination deficiency cancer testing…
NEW YORK – Thermo Fisher Scientific is throwing its hat into the ring of homologous recombination deficiency cancer testing…
Abstract Cancer progression is driven in part by genomic alterations1. The genomic characterization of cancers has shown…
Abstract Gains and losses of DNA are prevalent in cancer and emerge as a consequence of inter-related processes of replication…